Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | KSQ-001EX |
Trade Name | |
Synonyms | KSQ 001EX|KSQ001EX |
Drug Descriptions |
KSQ-001EX comprises autologous T-lymphocytes engineered to harbor inactivation of SOCS1, which potentially induces cytotoxicity in tumor cells and enhances antitumor immune response (Cancer Res (2024) 84 (6_Supplement): 20, NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C204100 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Aldesleukin + KSQ-001EX | Aldesleukin KSQ-001EX | 0 | 1 |
KSQ-001EX | KSQ-001EX | 0 | 1 |